Medicine
Ziagen 20 mg/mL oral solution
Ziagen 20 mg/mL oral solution is a prescription medicine containing Abacavir for oral use, marketed by ViiV Healthcare, with its source record on the US FDA register. It is available on request for export supply from India to licensed hospitals, importers and physicians. It ships in a temperature-controlled cold chain.
Availability
Export supply from India to licensed buyers
Typical lead time
On request
Counted from payment and complete documents
Shipping
Cold chain
DO NOT FREEZE. May be refrigerated. Store at controlled room temperature of…
Key facts
- Active ingredient (INN)
- Abacavir
- Brand
- Ziagen
- Strength
- 20 mg/mL
- Dosage form
- Oral solution
- Route
- Oral
- Packs
- 1 bottle
- Marketing authorisation holder
- ViiV Healthcare
- Manufacturer
- ViiV Healthcare
- Origin register
- US FDA, United States
- Storage
- DO NOT FREEZE. May be refrigerated. Store at controlled room temperature of 20° to 25°C (68° to 77°F).
- Cold chain
- Yes, shipped temperature controlled
- Prescription status
- Prescription only
- Controlled substance
- Not recorded as controlled
- ATC code
- J05AF06 Abacavir
- HS code (indicative)
- 3004.90Indicative only. Your customs broker confirms the final tariff code.
- Marketing category
- marketed
- Marketed since
- 28 January 1999
- Identifiers
- RxCUI 213461, 242680DailyMed set ID ca73b519-015a-436d-aa3c-af53492825a1NDC 49702-222Application NDA020978
Record updated 12 November 2026
Documents available
Documents that can be provided with this medicine. Your regulator may ask for more, and the quote lists the full set.
No document list is recorded for this medicine yet. Tell us which documents your regulator needs (for example a CoA, COPP or GMP certificate) when you request a quote.
Packs
| Pack | Code | Labeler | Marketed since |
|---|---|---|---|
| 1 bottle in 1 carton / 240 mL in 1 bottle | 49702-222-48 | ViiV Healthcare | 28 January 1999 |
Status by register
Where this medicine is registered, from the source record and the regulator data we hold. Ask us about a country that is not listed.
Import route
Pick the destination country to see the legal import route, who applies and typical timelines, from our import guide for that country.
Import guides are available for 25 countries. Pick one to see its route summary.
BrazilColombiaEgyptEthiopiaGhanaIraqKazakhstanKenyaAll import guides
Alternatives
Other makers and brands of Abacavir 20 mg/mL oral solution.
Other strengths and forms of Abacavir
Clinical summary
Abacavir is a human immunodeficiency virus nucleoside analog reverse transcriptase inhibitor indicated for the treatment of human immunodeficiency virus (HIV-1) infection. It is available as tablets, oral solution and kits. MedsAcross supplies Abacavir for export from India to licensed hospitals, importers and physicians acting for named patients, with the documents each country requires.
Information from the US FDA prescribing information, retrieved 12 November 2026. Not yet medically reviewed.How we review
Read about AbacavirFor healthcare professionals and buyers. This is not medical advice. Treatment decisions belong to the prescriber.
Data sources
- DailyMed label record · Checked 12 November 2026
- ZIAGEN prescribing information (ViiV Healthcare) · U.S. National Library of Medicine, DailyMed
- Ziagen: European public assessment report (EPAR) · European Medicines Agency
Need Ziagen 20 mg/mL oral solution for your hospital or patient?
Send one request with the destination country and quantity. We confirm availability, lead time and the documents your regulator needs.